Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis-Reference-Cited by-同舟云学术

Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis

Published:2018-04-25 Issue:12 Volume:47 Page:1578-1596
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Ma C.¹²^ORCID,Guizzetti L.²^ORCID,Panaccione R.¹,Fedorak R. N.³^ORCID,Pai R. K.²⁴^ORCID,Parker C. E.²,Nguyen T. M.²,Khanna R.²⁵,Vande Casteele N.²⁶^ORCID,D'Haens G.²⁷^ORCID,Sandborn W. J.²⁶^ORCID,Feagan B. G.²⁵⁸^ORCID,Jairath V.²⁵⁸^ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology; University of Calgary; Calgary AB Canada

2. Robarts Clinical Trials; Western University; London ON Canada

3. Division of Gastroenterology; University of Alberta; Edmonton AB Canada

4. Department of Pathology and Laboratory Medicine; Mayo Clinic Arizona; Scottsdale AZ USA

5. Department of Medicine; Western University; London ON Canada

6. Division of Gastroenterology; University of California San Diego; La Jolla CA USA

7. Inflammatory Bowel Disease Centre; Academic Medical Centre; Amsterdam The Netherlands

8. Department of Epidemiology and Biostatistics; Western University; London ON Canada

Funder

Institute of Nutrition, Metabolism and Diabetes

Canadian Association of Gastroenterology

Canadian Institutes of Health Research

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14672/fullpdf

Reference93 articles.

1. Current, new and future biological agents on the horizon for the treatment of inflammatory bowel diseases;Amiot;Therap Adv Gastroenterol,2015

2. Efficient early drug development for ulcerative colitis;Khanna;Gastroenterology,2016

3. A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis;Su;Gastroenterology,2007

4. Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis;Jairath;Cochrane Database Syst Rev,2017

5. Heterogeneity in definitions of endpoints for clinical trials of ulcerative colitis: a systematic review for development of a core outcome set;Ma;Clin Gastroenterol Hepatol,2017

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta‐analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control arm;Alimentary Pharmacology & Therapeutics;2023-02-24

2. Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysis;Inflammatory Bowel Diseases;2023-02-08

3. Applying Placebo and Nocebo Effects From Randomized Trials to Clinical Care and Future Studies;American Journal of Gastroenterology;2022-12-07

4. How to Minimize Placebo Response and Remission Rates;Inflammatory Bowel Diseases;2022-11-25

5. Placebo Rates in Randomized Controlled Trials of Proctitis Therapy: A Systematic Review and Meta-Analysis Placebo Response in Proctitis;Journal of Crohn's and Colitis;2022-08-05